Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaap ten Oever

Showing results (81-90 of 107) with videos related to

Pageof 11
Sort By:
JCI Insight|June 2, 2026
Age-related differences in immune responses to inactivated influenza and adjuvanted recombinant herpes zoster vaccinesGizem Kilic, Esther Jm Taks, Leonie S Helder, et al.
Plos One|March 26, 2021
Risk factors for in-hospital mortality in laboratory-confirmed COVID-19 patients in the Netherlands: A competing risk survival analysisGerine Nijman, Maike Wientjes, Jordache Ramjith, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 5, 2024
Low-Risk Staphylococcus aureus Bacteremia Patients Do Not Require Routine Diagnostic Imaging: A Multicenter, Retrospective, Cohort StudyMarianne M C Hendriks, Kris S A Schweren, Ayden Kleij, et al.
Iscience|October 20, 2023
The impact of Bacillus Calmette-Guérin vaccination on antibody response after COVID-19 vaccinationEsther J M Taks, Simone J C F M Moorlag, Konstantin Föhse, et al.
Open Forum Infectious Diseases|February 3, 2016
The Effect of Rosuvastatin on Markers of Immune Activation in Treatment-Naive Human Immunodeficiency Virus-PatientsRobyn G M Weijma, Eric R A Vos, Jaap Ten Oever, et al.
Med (New York, N.Y.)|September 27, 2021
Interferon gamma immunotherapy in five critically ill COVID-19 patients with impaired cellular immunity: A case seriesArjan van Laarhoven, Lisa Kurver, Gijs J Overheul, et al.
The Journal of Infection|November 8, 2024
The effect of BCG vaccination in the elderly on infectious and non-infectious immune-mediated diseasesElisabeth A Dulfer, Konstantin Föhse, Esther J M Taks, et al.
Journal of Infection and Public Health|February 17, 2026
Early risk assessment of severe outcomes in patients with suspected infection in the emergency department using clinical scores in a multicenter international validationCarolina Hincapié-Osorno, Tamar J van der Aart, Raymond J van Wijk, et al.
Thrombosis Research|February 12, 2008
Plasma PAI-1 levels are independently related to fatty liver and hypertriglyceridemia in familial combined hyperlipidemia, involvement of apolipoprotein EMartijn C G J Brouwers, Jose Govers-Riemslag, Casper G Schalkwijk, et al.
Trials|June 24, 2020
Correction to: Two Randomized Controlled Trials of Bacillus Calmette-Guérin Vaccination to reduce absenteeism among health care workers and hospital admission by elderly persons during the COVID-19 pandemic: A structured summary of the study protocols for two randomised controlled trialsThijs Ten Doesschate, Simone J C F M Moorlag, Thomas W van der Vaart, et al.
Pageof 11

Showing results (81-90 of 107) with videos related to

Sort By:
Pageof 11
JCI Insight|June 2, 2026
Age-related differences in immune responses to inactivated influenza and adjuvanted recombinant herpes zoster vaccinesGizem Kilic, Esther Jm Taks, Leonie S Helder, et al.
Plos One|March 26, 2021
Risk factors for in-hospital mortality in laboratory-confirmed COVID-19 patients in the Netherlands: A competing risk survival analysisGerine Nijman, Maike Wientjes, Jordache Ramjith, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 5, 2024
Low-Risk Staphylococcus aureus Bacteremia Patients Do Not Require Routine Diagnostic Imaging: A Multicenter, Retrospective, Cohort StudyMarianne M C Hendriks, Kris S A Schweren, Ayden Kleij, et al.
Iscience|October 20, 2023
The impact of Bacillus Calmette-Guérin vaccination on antibody response after COVID-19 vaccinationEsther J M Taks, Simone J C F M Moorlag, Konstantin Föhse, et al.
Open Forum Infectious Diseases|February 3, 2016
The Effect of Rosuvastatin on Markers of Immune Activation in Treatment-Naive Human Immunodeficiency Virus-PatientsRobyn G M Weijma, Eric R A Vos, Jaap Ten Oever, et al.
Med (New York, N.Y.)|September 27, 2021
Interferon gamma immunotherapy in five critically ill COVID-19 patients with impaired cellular immunity: A case seriesArjan van Laarhoven, Lisa Kurver, Gijs J Overheul, et al.
The Journal of Infection|November 8, 2024
The effect of BCG vaccination in the elderly on infectious and non-infectious immune-mediated diseasesElisabeth A Dulfer, Konstantin Föhse, Esther J M Taks, et al.
Journal of Infection and Public Health|February 17, 2026
Early risk assessment of severe outcomes in patients with suspected infection in the emergency department using clinical scores in a multicenter international validationCarolina Hincapié-Osorno, Tamar J van der Aart, Raymond J van Wijk, et al.
Thrombosis Research|February 12, 2008
Plasma PAI-1 levels are independently related to fatty liver and hypertriglyceridemia in familial combined hyperlipidemia, involvement of apolipoprotein EMartijn C G J Brouwers, Jose Govers-Riemslag, Casper G Schalkwijk, et al.
Trials|June 24, 2020
Correction to: Two Randomized Controlled Trials of Bacillus Calmette-Guérin Vaccination to reduce absenteeism among health care workers and hospital admission by elderly persons during the COVID-19 pandemic: A structured summary of the study protocols for two randomised controlled trialsThijs Ten Doesschate, Simone J C F M Moorlag, Thomas W van der Vaart, et al.
Pageof 11